Dogwood Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Dogwood Therapeutics Total Assets Growth & History (DWTX)
Dogwood Therapeutics's total assets was $90.2M for fiscal 2025.
View full Dogwood Therapeutics company overviewDogwood Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $90.2M | −$4.1M | −4.39% |
| 2024 | 2024-12-31 | $94.3M | $90.1M | +2164.06% |
| 2023 | 2023-12-31 | $4.2M | −$4.2M | −50.23% |
| 2022 | 2022-12-31 | $8.4M | −$7.4M | −46.95% |
| 2021 | 2021-12-31 | $15.8M | −$15.7M | −49.87% |
| 2020 | 2020-12-31 | $31.5M | — | — |
Dogwood Therapeutics quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $80.5M | −$16.2M | −16.75% |
| Q1 2026 | 2026-03-31 | $95.2M | −$1.8M | −1.83% |
| Q4 2025 | 2025-12-31 | $90.2M | −$4.1M | −4.39% |
| Q3 2025 | 2025-09-30 | $92.0M | $89.7M | +3929.02% |
| Q2 2025 | 2025-06-30 | $96.7M | $93.1M | +2559.39% |
| Q1 2025 | 2025-03-31 | $97.0M | $93.8M | +2907.64% |
| Q4 2024 | 2024-12-31 | $94.3M | $90.1M | +2164.06% |
| Q3 2024 | 2024-09-30 | $2.3M | −$3.0M | −56.50% |
| Q2 2024 | 2024-06-30 | $3.6M | −$1.6M | −30.24% |
| Q1 2024 | 2024-03-31 | $3.2M | −$3.3M | −50.55% |
| Q4 2023 | 2023-12-31 | $4.2M | −$4.2M | −50.23% |
| Q3 2023 | 2023-09-30 | $5.2M | −$5.6M | −51.66% |
| Q2 2023 | 2023-06-30 | $5.2M | −$3.8M | −42.34% |
| Q1 2023 | 2023-03-31 | $6.5M | −$6.0M | −48.04% |
| Q4 2022 | 2022-12-31 | $8.4M | −$7.4M | −46.95% |
| Q3 2022 | 2022-09-30 | $10.9M | −$9.2M | −46.00% |
| Q2 2022 | 2022-06-30 | $9.0M | −$14.7M | −61.96% |
| Q1 2022 | 2022-03-31 | $12.5M | −$15.7M | −55.61% |
| Q4 2021 | 2021-12-31 | $15.8M | −$15.7M | −49.87% |
| Q3 2021 | 2021-09-30 | $20.1M | — | — |
| Q2 2021 | 2021-06-30 | $23.8M | — | — |
| Q1 2021 | 2021-03-31 | $28.3M | — | — |
| Q4 2020 | 2020-12-31 | $31.5M | — | — |
Dogwood Therapeutics total assets trends
Over the last five fiscal years, Dogwood Therapeutics's total assets increased from $31.5M to $90.2M, a change of $58.7M. The latest reported quarter, Q2 2026, shows $80.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dogwood Therapeutics source filings ↗